These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 5704055)

  • 1. [Ethambutol in association with isonicotinic acid hydrazide in the therapy of pulmonary tuberculosis primary infection. (Case reports and comparison with the association of streptomycin and isoniazid)].
    Briccarello L; Ferraro U; Vercellino E
    G Ital Mal Torace; 1968; 22(2):81-9. PubMed ID: 5704055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 3. Two phase chemotherapy with streptomycin isoniazid and ethambutol, followed by isoniazid and ethambutol.
    Purohit SD; Sharma GS; Bomb BS
    J Assoc Physicians India; 1975 Jun; 23(6):385-9. PubMed ID: 1184566
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tubercular treatment in patients with hepatitis.
    Deshpande DV; Nachne D; Koyande D; Rodriques CJ
    J Assoc Physicians India; 1991 Aug; 39(8):599-601. PubMed ID: 1814872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Streptomycin, isoniazid and ethambutol in continuous and intermittent treatment of previously untreated pulmonary tuberculosis].
    Zierski M; Bek E
    Gruzlica; 1972; 40(12):1165-74. PubMed ID: 4648079
    [No Abstract]   [Full Text] [Related]  

  • 6. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 7. Intermittent chemotherapy in pulmonary tuberculosis with ethambutol and isoniazid.
    Krishnaswami KV; Seshagiri K
    Indian J Chest Dis; 1973 Jan; 15(1):2-9. PubMed ID: 4695465
    [No Abstract]   [Full Text] [Related]  

  • 8. [Madras study on intermittent oral chemotherapy using ethambutol and isoniazid].
    Tripathy SP
    Bull Int Union Tuberc; 1974; 49(1):427-34. PubMed ID: 4619563
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethambutol in primary childhood tuberculosis.
    Patwardhan P; Bhatia M; Merchant SM
    Indian Pediatr; 1970 Apr; 7(4):194-201. PubMed ID: 5311827
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethambutol-isoniazid versus streptomycin-ethambutol-isoniazid in original treatment of cavitary tuberculosis.
    Bobrowitz ID
    Am Rev Respir Dis; 1974 May; 109(5):548-53. PubMed ID: 4207273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modern tuberculosis therapy].
    Krohn J
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract]   [Full Text] [Related]  

  • 15. [Follow-up studies up to 2 years of pulmonary tuberculosis patients submitted to the primary chemotherapy for 1 year with multiple drugs including ethambutol].
    Kekkaku; 1973 Apr; 48(4):135-41. PubMed ID: 4721805
    [No Abstract]   [Full Text] [Related]  

  • 16. [A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1974 Aug; 49(8):247-52. PubMed ID: 4427402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current aspects in treatment of tuberculosis].
    Tala E
    Duodecim; 1976; 92(10):505-13. PubMed ID: 1084829
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
    Sighart H; Opl G
    Wien Klin Wochenschr; 1969 Nov; 81(46):840-1. PubMed ID: 5380791
    [No Abstract]   [Full Text] [Related]  

  • 20. Antituberculous therapy in pregnancy. Risks to the fetus.
    Scheinhorn DJ; Angelillo VA
    West J Med; 1977 Sep; 127(3):195-8. PubMed ID: 906455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.